S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68

Nuvo Pharmaceuticals Earnings Date, Estimates, & History

0.00 (0.00%)
(As of 05/20/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Average Volume
801 shs
Market Capitalization
$7.09 million
P/E Ratio
Dividend Yield

Earnings Summary

Skip Charts & View Estimated and Actual Earnings Data

Nuvo Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Nuvo Pharmaceuticals Estimated Revenue and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

MRVFF Earnings Information

Nuvo Pharmaceuticals last announced its quarterly earnings results on March 28th, 2022. The reported ($0.18) earnings per share for the quarter. The firm had revenue of $14.05 million for the quarter. Nuvo Pharmaceuticals has generated ($1.56) earnings per share over the last year (($1.56) diluted earnings per share).

Nuvo Pharmaceuticals (OTCMKTS:MRVFF) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueActions
3/28/2022Q4 2021($0.18)($0.18)$0.03$14.05 million
11/15/2021Q3 2021($0.27)($0.27)$0.70$13.49 million
8/9/2021Q2 2021($0.07)($0.07)($0.22)$16.11 million
5/17/2021Q1 2021($0.02)($0.02)$1.21$11.39 million
3/8/2021Q4 2020$0.04+$0.04$0.04$13.26 million
11/16/2020Q3 2020$0.07+$0.07$0.33$12.46 million
11/16/2020Q3 2020$0.13$0.09($0.04)$0.43$16.40 million$16.60 million
8/10/2020Q2 2020($0.12)($0.12)($0.12)$11.20 million
8/10/2020Q2 2020($0.17)($0.17)($0.17)$14.70 million$15.53 million
5/11/2020Q1 2020$0.12+$0.12$0.12$18.16 million
5/11/2020Q1 2020$0.16+$0.16$0.16$24.36 million
2/25/2020Q4 2019$0.23+$0.23$0.23$14.85 million
2/25/2020Q4 2019($0.05)$0.30+$0.35$0.30$16.20 million$19.59 million
10/31/2019Q3 2019$0.01+$0.01($0.06)$14.26 million
10/31/2019Q3 2019($0.03)$0.01+$0.04($0.08)$16.10 million$18.82 million
8/14/2019Q2 2019($0.54)($0.54)($0.69)$12.40 million
8/14/2019Q2 2019($0.28)($0.72)($0.44)($0.92)$15.30 million$16.58 million
5/14/2019Q1 2019($0.15)($0.15)$0.19$10.94 million
5/14/2019Q1 2019($0.21)($0.19)+$0.02$0.27$13.00 million$14.55 million
3/29/2019Q4 2018($0.28)($0.28)($0.25)$3.49 million
3/29/2019Q4 2018($0.37)($0.37)($0.33)$4.50 million$4.61 million
11/8/2018Q3 2018$0.03+$0.03$0.22$3.89 million
11/8/2018Q3 2018$0.03$0.04+$0.01$0.29$4.90 million$5.09 million
8/2/2018Q2 2018$0.07+$0.07$0.07$4.55 million
8/2/2018Q2 2018$0.01$0.09+$0.08$0.09$5.88 million
5/10/2018Q1 2018$0.02+$0.02$0.05$3.51 million
5/10/2018Q1 2018$0.02$0.02$0.05$4.43 million
3/23/2018Q4 2017($0.02)($0.02)($0.02)$3.53 million
3/23/2018Q4 2017$0.15($0.02)($0.17)($0.02)$4.49 million
11/1/2017Q3 2017($0.02)($0.02)($0.02)$2.36 million
11/1/2017Q3 2017$0.07($0.02)($0.09)($0.02)$2.96 million
8/9/2017Q2 2017($0.02)($0.02)($0.02)$2.31 million
8/9/2017Q2 2017($0.07)($0.02)+$0.05($0.02)$3.10 million
5/10/2017Q1 2017$0.14+$0.14$0.14$5.27 million
5/10/2017Q1 2017$0.17$0.19+$0.02$0.19$6.98 million
3/1/2017Q4 2016$0.11+$0.11$0.11$4.18 million
3/1/2017Q4 2016$0.24$0.12($0.12)$0.12$5.57 million
11/10/2016Q3 2016$0.07+$0.07$0.07$4.23 million
11/10/2016Q3 2016$0.22$0.10($0.12)$0.10$5.52 million
8/10/2016Q2 2016$0.16+$0.16$0.16$6.29 million
8/10/2016Q2 2016$0.21+$0.21$0.21$8.11 million
5/11/2016Q1 2016$0.11+$0.11$0.30$5.72 million
5/11/2016Q1 2016$0.15+$0.15$0.41$7.84 million
2/17/2016Q4 2015$0.02+$0.02$0.02$5.88 million
2/17/2016Q4 2015($0.38)$0.03+$0.41$0.03$4.70 million$7.84 million
11/10/2015Q3 2015($0.08)($0.08)($0.08)$4.37 million
11/10/2015Q3 2015($0.40)($0.11)+$0.29($0.11)$3.80 million$5.72 million
8/5/2015Q2 2015($0.45)($0.45)($0.45)$2.64 million
8/5/2015Q2 2015($0.10)($0.55)($0.45)($0.55)$3.80 million$3.25 million
5/12/2015Q1 2015($0.02)($0.02)($0.02)$3.67 million
5/12/2015Q1 2015($0.39)($0.03)+$0.36($0.03)$2.90 million$4.50 million
2/19/2015Q4 2014($0.49)($0.49)($0.49)$2.99 million
2/19/2015Q4 2014($0.30)($0.56)($0.26)($0.56)$3.40 million$3.40 million
11/10/2014Q3 2014($0.23)($0.23)($4.87)$2.76 million
11/10/2014Q3 2014($0.28)($0.25)+$0.03($5.30)$3.40 million$3.01 million
7/30/2014Q2 2014($0.21)($0.21)($0.21)$3.54 million
7/30/2014Q2 2014($0.25)($0.23)+$0.02($0.23)$3.30 million$3.86 million
4/30/2014Q1 2014($0.28)($0.28)($0.28)$2.51 million
4/30/2014Q1 2014($0.31)($0.31)($0.31)$2.76 million
2/20/2014Q4 2013($0.21)($0.21)($0.21)$1.29 million
2/20/2014Q4 2013($0.38)($0.22)+$0.16($0.22)$2.80 million$1.33 million
10/30/2013Q3 2013$0.37+$0.37$1.07$0.80 million
10/30/2013Q3 2013$0.36$0.39+$0.03$1.12$8.48 million$0.83 million
7/31/2013Q2 2013($0.24)($0.24)($0.24)$1.63 million
7/31/2013Q2 2013($0.16)($0.25)($0.09)($0.25)$4.01 million$1.67 million
5/1/2013Q1 2013($0.38)($0.38)($0.38)$0.60 million
5/1/2013Q1 2013($24.68)($24.68)($24.68)$3.73 million$0.60 million
10/31/2012Q3 2012$0.65+$0.65$0.65
8/1/2012Q2 2012$0.39+$0.39$0.39
5/2/2012Q1 2012($0.26)($0.26)($0.26)
2/29/2012Q4 2011($0.32)($0.32)($0.32)
11/2/2011Q3 2011($0.19)($0.19)($0.19)
8/10/2011Q2 2011($0.19)($0.19)($0.38)
5/26/2011Q1 2011($0.65)($0.65)($0.65)
2/24/2011Q4 2010($0.26)($0.26)($0.26)
10/27/2010Q3 2010($0.32)($0.32)($0.32)
7/29/2010Q2 2010($0.45)($0.45)($0.45)
4/29/2010Q1 2010($0.52)($0.52)($0.52)
2/19/2010Q4 2009$3.90+$3.90$3.90
10/28/2009Q3 2009($0.45)($0.45)($0.45)
8/7/2009Q2 2009($0.32)($0.32)($0.32)
4/30/2009Q1 2009($0.58)($0.58)($0.58)
10/30/2008Q3 2008($0.65)($0.65)($0.65)
7/31/2008Q2 2008($0.58)($0.58)($0.58)
5/1/2008Q1 2008($0.52)($0.52)($0.52)
(Earnings results data provided by Zacks Investment Research)

Nuvo Pharmaceuticals (OTCMKTS:MRVFF) Earnings Frequently Asked Questions

When did Nuvo Pharmaceuticals announce their last quarterly earnings?

Nuvo Pharmaceuticals (OTCMKTS:MRVFF) last announced its quarterly earning data on Monday, March 28, 2022. Learn more on MRVFF's earnings history.

How much revenue does Nuvo Pharmaceuticals generate each year?

Nuvo Pharmaceuticals (OTCMKTS:MRVFF) has a recorded annual revenue of $54.98 million.

How much profit does Nuvo Pharmaceuticals generate each year?

Nuvo Pharmaceuticals (OTCMKTS:MRVFF) has a recorded net income of -$25.69 million. MRVFF has generated -$1.56 earnings per share over the last four quarters.

This page was last updated on 5/21/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.